← Back to Search

Indocyanine Green Dye for Bone Tumors

Q: Approximately how many individuals have enrolled in the clinical trial?

<p>At present, there are no opportunities to join this trial. The clinicaltrial was initially announced on November 11th 2021 and the most recent change took place a few days later, on November 20th 2021. If you're looking for alternative trials, 46 studies involving <a href="https://www.withpower.com/clinical-trials/bone-cancer">bone cancer</a> are currently recruiting participants while 30 others focusing on Indocyanine Green have vacancies available.</p>

Q: Are there any vacancies available in this clinical trial?

<p>This trial is now closed to new participants. The initial posting date was November 11th 2021, and the last update occurred on November 20th 2021. If you are seeking alternative medical studies, there are currently 46 trials recruiting patients with <a href="https://www.withpower.com/clinical-trials/bone-cancer">bone cancer</a> while 30 different clinical experiments are enrolling those afflicted by Indocyanine Green.</p>

Phase < 1

Waitlist Available

Led By Eric R Henderson, MD

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 hours post injection

Awards & highlights

Study Summary

This trial is testing whether adding a dye to help surgeons see margins of the tumor during surgery can improve outcomes for patients with a type of bone tumor.

Who is the study for?

This trial is for patients aged 12 or older with benign bone tumors, such as Enchondroma or Osteochondroma, among others. They must consent to treatment and not be pregnant, breastfeeding, incarcerated, or allergic to iodine. The tumor should be manageable with intralesional surgery.Check my eligibility

What is being tested?

The study tests the use of Indocyanine Green (ICG), an FDA-approved dye given intravenously before surgery. It aims to see if ICG helps visualize the tumor better during operation using a special fluorescence camera.See study design

What are the potential side effects?

Potential side effects of ICG include mild reactions at the injection site and rare cases of allergy-like symptoms due to iodine content in the dye.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 hours post injection

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 hours post injection

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours post injection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Fluorescent intensity contrast

Trial Design

1Treatment groups

Experimental Treatment

Group I: Benign Bone patientsExperimental Treatment1 Intervention

Patients with Benign Bone tumors requiring intralesional operative management will be administered immunofluorescent indocyanine green 24 hours prior to surgery, imaging of perfused tissues will be performed at the time of tumor removal.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Indocyanine Green

2008

Completed Phase 2

~1050

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor

524 Previous Clinical Trials

2,543,339 Total Patients Enrolled

Eric R Henderson, MDPrincipal InvestigatorDartmouth-Hithcock Medical Center

2 Previous Clinical Trials

27 Total Patients Enrolled

Media Library

Indocyanine Green Clinical Trial Eligibility Overview. Trial Name: NCT05075889 — Phase < 1

Bone Tumors Research Study Groups: Benign Bone patients

Bone Tumors Clinical Trial 2023: Indocyanine Green Highlights & Side Effects. Trial Name: NCT05075889 — Phase < 1

Indocyanine Green 2023 Treatment Timeline for Medical Study. Trial Name: NCT05075889 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Approximately how many individuals have enrolled in the clinical trial?

"At present, there are no opportunities to join this trial. The clinicaltrial was initially announced on November 11th 2021 and the most recent change took place a few days later, on November 20th 2021. If you're looking for alternative trials, 46 studies involving bone cancer are currently recruiting participants while 30 others focusing on Indocyanine Green have vacancies available."

Answered by AI

Are there any vacancies available in this clinical trial?

"This trial is now closed to new participants. The initial posting date was November 11th 2021, and the last update occurred on November 20th 2021. If you are seeking alternative medical studies, there are currently 46 trials recruiting patients with bone cancer while 30 different clinical experiments are enrolling those afflicted by Indocyanine Green."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Utility of ICG in Benign Bone Tumors

Eric R. Henderson 2021. "Utility of ICG in Benign Bone Tumors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05075889.